-------如果这里没有任何信息，不是真没有，是我们懒！请复制书名上amazon搜索书籍信息。-------
by Sara Hurvitz MD (Author), Kelly McCann (Author)Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today’s available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists.Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive.Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations.Includes a timely section on innovative future therapies.Product DetailsPaperback: 264 pagesPublisher: Elsevier; 1 edition (August 30, 2018)Language: EnglishISBN-10: 0323581226ISBN-13: 978-0323581226 Product Dimensions: 7.8 x 9.4 inches
